Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
X-Linked Combined Immunodeficiency Diseases
0.100 AlteredExpression group BEFREE A novel intronic splice site deletion of the IL-2 receptor common gamma chain results in expression of a dysfunctional protein and T-cell-positive X-linked Severe combined immunodeficiency. 25443657 2015
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE X-linked severe combined immunodeficiency (X-SCID) leads to a T(-) NK(-) B(+) immunophenotype and is caused by mutations in the gene encoding the IL-2 receptor γ-chain (IL2RG). 25042067 2014
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Patients with X-linked severe combined immunodeficiency (SCID-X1) were successfully cured following gene therapy with a gamma-retroviral vector (gRV) expressing the common gamma chain of the interleukin-2 receptor (IL2RG). 22551777 2012
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Along with IL-4, IL-7, IL-9, IL-15, and IL-21, IL-2 shares the common cytokine receptor γ chain, γ(c), which is mutated in humans with X-linked severe combined immunodeficiency. 21889323 2011
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE In conclusion, we have identified the novel mutation in the IL-2 receptor gamma chain gene, which is associated with X-SCID. 19398866 2009
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE Finally, we describe the construction of an insulated, SIN lentiviral vector encoding the human interleukin 2 receptor common gamma chain (IL2RG) gene and the efficient derivation of cloned producer cells that generate supernatants with titers greater than 5 x 10(7) TU/mL and that are suitable for use in a clinical trial for X-linked severe combined immunodeficiency (SCID-X1). 19286997 2009
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Previously, several individuals with X-linked SCID (SCID-X1) were treated by gene therapy to restore the missing IL-2 receptor gamma (IL2RG) gene to CD34+ BM precursor cells using gammaretroviral vectors. 18688285 2008
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Retroviral gene therapy can restore immunity to infants with X-linked severe combined immunodeficiency (XSCID) caused by mutations in the IL2RG gene encoding the common gamma chain (gammac) of receptors for interleukins 2 (IL-2), -4, -7, -9, -15, and -21. 17369490 2007
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE X-linked severe combined immunodeficiency (X-SCID) is a rare, life-threatening immune disorder, caused by mutations in the gamma c chain gene, which encodes an essential component of the cytokine receptors for interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15, and IL-21. 14966353 2004
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Our laboratory has identified an X-linked severe combined immunodeficiency (XSCID) in dogs that is the result of mutations in the common gamma chain (gammac) subunit of the interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15, and IL-21 receptors. 12857971 2003
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model. 11319919 2001
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Canine X-linked severe combined immunodeficiency (XSCID) is due to mutations in the common gamma (gammac) subunit of the IL-2, IL-4, IL-7, IL-9 and IL-15 receptors and has a similar clinical phenotype to human XSCID. 10889304 2000
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action. 9933465 1999
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE The phenotypic differences between X-SCID and IL-2-deficient SCID suggests that the IL-2Rgamma chain might be a component of other receptors needed for thymic development, B cell class-switching, and NK development. 9801259 1998
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE X-linked severe combined immunodeficiency (XSCID) constitutes a disorder of the immune system caused by mutations in the gene encoding the common gamma chain (gammac), a subunit of the IL-2, IL-4, IL-7, IL-9 and IL-15 receptors, which are necessary for lymphocyte development and function. 9921912 1998
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Our laboratory has identified and characterized an X-linked severe combined immunodeficiency (XSCID) in dogs that is due to mutations in the common gamma (gamma c) subunit of the interleukin-2 (IL2), IL4, IL7, IL9, and IL15 receptors. 9479568 1998
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE Both canine and human XSCID are caused by defects in the common gamma chain, gammac, of receptors for interleukin-2 and other cytokines. 9716584 1998
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE The diagnosis of X-linked SCID is usually relatively simple due to the distinctive immunological presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+). 9399950 1997
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE The gamma(c) subunit can be employed in receptor complexes for IL-2, -4, -7, -9, and -15, and the multiple signaling defects that would result from a defective gamma(c) chain in these receptors are proposed to cause the severe phenotype of X-SCID patients. 9005984 1997
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE The fact that the phenotype and clinical manifestations in XSCID are more severe than the abnormalities found in humans or mice deficient in IL-2 led to the speculation and subsequent confirmation that the IL-2 receptor is not the only receptor to contain the gamma chain. 8712778 1996
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE Our results emphasize the broad molecular heterogeneity of X-linked SCID and suggest the presence of mutational "hot spots" within the IL-2R gamma-chain gene. 8956936 1996
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE Thus, retroviral-mediated transduction of normal gamma-c can reconstitute downstream signalling through the IL-2R in X-SCID cell lines, suggesting that gene therapy may be a treatment for this disease. 8605323 1996
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE Mutation of the gamma c chain common to interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15 receptors has been shown to be responsible for the X chromosome-linked severe combined immune deficiency (SCIDX1). 8781427 1996
X-Linked Combined Immunodeficiency Diseases
0.100 GeneticVariation group BEFREE X-linked severe combined immunodeficiency (XSCID) is a lethal disease caused by a defect in the gene encoding the common gamma chain (gamma-c) of the receptor for interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15. 8605322 1996
X-Linked Combined Immunodeficiency Diseases
0.100 Biomarker group BEFREE JAK3-deficient patients present with a clinical phenotype virtually indistinguishable from boys affected by X-linked SCID, a disease caused by genetic defects of the common gamma chain (gamma c) that is a shared component of the receptors for IL-2, IL-4, IL-7, IL-9, and IL-15. 8676091 1996